Researchers have discovered and analysed a rare but serious side effect of an innovative form of blood cancer therapy.

24 Although the benefit of CAR T-cell therapy for multiple myeloma continues to outweigh the risk, vigilant monitoring for T-cell lymphoma should be implemented. Supported by Johnson & Johnson and ...

Therapy timing, patient factors, and emerging combination interventions are guiding treatment decisions in multiple myeloma and lymphoma.

director of the Cornell Center for Lymphoma and Myeloma at Weill Cornell Medical Center, tells WebMD. Lymphomas result when certain blood cells, called lymphocytes, multiply and refuse to obey ...

July 22, 2024 — The researchers report the ability of protein 'signatures' to predict the onset of 67 diseases including multiple myeloma, non-Hodgkin lymphoma, motor neurone disease ...

They are referred to as leukaemia, lymphoma and myeloma depending on the type of cell affected. The three types of malignancies are connected through the immune system and, generally, a disease ...

Residual disease can now be tracked in hematological malignancies, including leukemia, lymphoma and myeloma, and the benefits of these MRD tests have grown in tandem with their sensitivity and ...

Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

A father-of-two who is in remission from cancer is calling for the treatment which helped him to be made available on the NHS. Jason Johnson was diagnosed with myeloma - a form of bone cancer - in ...

Antengene’s new drug application (NDA) for Xpovio (selinexor) has gained approval from the Indonesia National Agency of Drug ...

Planning Activities Are Ongoing for Next Phase of Cemsidomide Clinical Development in Multiple Myeloma and Non-Hodgkin’s Lymphoma; Trials ...